SDHB-associated PCC/PGL have the highest rates of developing metastatic disease, with estimates of about 25–50% depending on the study (Jochmanova et al. 2017, Niemeijer et al. 2017). The gene discussed is SDHB; the disease is metastatic neoplasm.